Lavjay Butani is a Nephrology physician affiliated with University of California Davis Medical Center. OpenAlex indexes 182 publications with 1,957 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2516 Stockton Blvd
Ticon Ii, 3rd Floor
Sacramento, CA 958172208
Telephone
916-734-8118Registry record last updated 8 Nov 2011.
Clinical trials
- Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds
Sponsor: University of California, Davis
- Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Sponsor: University of California, Davis
- National Cooperative Growth Study in CKD
Sponsor: University of California, Davis
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20241 payment
- Alexion Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.4%Calcium channel blocker34.8%Katerzia100%Part D<11 patientsBeta blocker32.6%Labetalol Hcl100%Part D<11 patientsCancer & immunology
32.6%Calcineurin inhibitor32.6%Tacrolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature
Recent Patents on Inflammation & Allergy Drug Discovery
2019 - Effect of BMI on allograft function and survival in pediatric renal transplant recipients
Pediatric Nephrology
2018 - Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients
Pediatric Nephrology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Helen Chew, MD
University of California Davis Medical Center
Marcio Malogolowkin, MD
University of California Davis Medical Center
Glenn Yiu, MD, PhD
University of California Davis Medical Center
Namita Sood, MD
University of California Davis Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”